_flow-cytometry-in-chronic-myeloid-neoplasms-current-recommendations-and-challenges.jpg "Flow cytometry in Chronic Myeloid Neoplasms: Current Recommendations and Challenges from flow cytometric analysis Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 31 min 3 sec
✓ Published: 22-May-2023
✓ Published: 22-May-2023
Description:
The role of flow cytometric immunophenotyping (FCIP) in the diagnosis and follow up of lymphoproliferative disorders, plasma cell neoplasms and acute leukemias is well established. However, its value in chronic myeloid neoplasms remains debatable. Systemic mastocytosis, and more recently chronic myelomonocytic leukemia, are the only two groups for which immunophenotypic characterization is incorporated into the diagnostic criteria. Over the past two decades, several studies have demonstrated a v
The role of flow cytometric immunophenotyping (FCIP) in the diagnosis and follow up of lymphoproliferative disorders, plasma cell neoplasms and acute leukemias is well established. However, its value in chronic myeloid neoplasms remains debatable. Systemic mastocytosis, and more recently chronic myelomonocytic leukemia, are the only two groups for which immunophenotypic characterization is incorporated into the diagnostic criteria. Over the past two decades, several studies have demonstrated a v
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_advanced-flow-cytometry-techniques-to-functionally-characterize-immunotherapies.webp "With accelerating development and approval of cell therapies and biologic drugs comes a need for more robust and reliable cell-based assays and validated analysis systems. In this seminar a variety of techniques for immune cell isolation, expansion, and characterization will be demonstrated in cell-based immunotherapy models using powerful cytometric instrumentation. Special focus will be given to immune effector function assays to characterize the potency and specificity of CAR-T and NK cells.")
⏲ 18 min 95 sec ✓ 17-Jul-2020
_flow-cytometry-analysis.webp "JoVE (Journal of Visualized Experiments)")
_flow-cytometry-in-1-minute.webp "Henrik's Lab")
_an-introduction-to-flow-cytometric-analysis-part-2-cell-viability-and-apoptosis-analysis.webp "Thermo Fisher Scientific")
⏲ 52 minutes 13 seconds 👁 7.9K
_flow-cytometry-tutorial-124-flow-cytometry-data-analysis-124-flow-cytometry-gating.webp "Biology Lectures")
⏲ 21 minutes 16 seconds 👁 61.4K
_flow-cytometric-analysis-of-hematologic-malignancies-by-use-of-the-clearllab-lymphoid-screening-tub.webp "Watch this presentation by Prof. Dr. med. Wolfgang Kern, MLL Munich Leukemia Laboratory, titled: Flow cytometric analysis of hematologic malignancies by use of the ClearLLab Lymphoid Screening Tube. This talk was presented at the SelectScience® Virtual Clinical Science Summit 2021.")
⏲ 15 min 92 sec ✓ 11-Mar-2024
_lecture-7b-flow-cytometry.webp "Annelise Snyder")
_advanced-flow-cytometry-techniques-to-functionally-characterize-immunotherapies.jpg)
_flow-cytometry-analysis.jpg)
_flow-cytometry-in-1-minute.jpg)
_an-introduction-to-flow-cytometric-analysis-part-2-cell-viability-and-apoptosis-analysis.jpg)
_flow-cytometry-tutorial-124-flow-cytometry-data-analysis-124-flow-cytometry-gating.jpg)
_flow-cytometric-analysis-of-hematologic-malignancies-by-use-of-the-clearllab-lymphoid-screening-tub.jpg)
_lecture-7b-flow-cytometry.jpg)
![[+]](/images/menu.gif){kind=small}